- Two studies focusing on the most promising coronavirus drugs just delivered bad news about the COVID-19 treatments.
- An observational hydroxychloroquine study from New York revealed the drug failed to show any promise on COVID-19 patients experiencing severe symptoms.
- In addition, a randomized remdesivir clinical trial from China revealed the drug had no effect on patients experiencing severe coronavirus cases.
- Visit BGR’s homepage for more stories.
More than four months after the emergence of the novel coronavirus, the world is still stuck mostly indoors as it looks to reduce the spread of the virus and prevent medical systems from collapsing. We still don’t have a drug that works against COVID-19 or a vaccine, but that’s because we’re only getting started. A vaccine will likely be ready for mass inoculations in 12 to 18 months. Before that happens, we’ll also know whether any of the promising COVID-19 treatments that you’ve heard about on TV actually work. New results are already here for two of these promising drugs, but neither shows any promise. The good news is that they’re not definitive and more research is required on both hydroxychloroquine and remdesivir.
Today’s Top Deals
- Hurry: Amazon’s best-selling face masks are somehow still in stock
- Today’s best deals: 78¢ face masks, $8 wireless charger, UV phone sanitizer, AirPods Pro, Roku, rare Bose deal, more
- Today’s best deals: Face masks in stock, UV phone sanitizers, crazy Fire HD 8 Tablet deal, rare Bose 700 sale, more
Trending Right Now:
- Where’s my stimulus check? A new reason your money might be delayed
- The most unusual coronavirus symptom is also the most dangerous
- A promising coronavirus vaccine already works on monkeys
Two promising coronavirus drugs just failed in clinical trials originally appeared on BGR.com on Fri, 24 Apr 2020 at 16:50:52 EDT. Please see our terms for use of feeds.
Read more here:: Boy Genius Report